See inside every stock. Pro
S&P 5007,723▲ 0.60%Nasdaq26,478▲ 1.18%Dow Jones52,378▲ 0.03%Nasdaq 10029,651▲ 1.29%VIX17.52▼ 4.73%US Dollar102.35▲ 0.39%Gold spot4,006▲ 0.30%WTI101.35▲ 1.45%
← VIRI page
XStocksXray
Market X-Ray report · 27 October 2026

Viridien (VIRI)

Euronext Paris · France · prices in EUR · close of 27 Oct 2026

Key indicators

Last closeEUR 95.90
52-week range73.00 – 161.40
Return, 1 month / 3 months+4.0% / +13.9%
Return, 1 year / 3 years+27.4% / +47.8%
TrendBelow its 200-day average
RSI (14)60
Volatility (1 year)65.2%
Worst drawdown (1 year)-50.4%
Average daily value traded2.77M EUR
Dividend yield–

Market X-Ray price-based

49/ 100 · High confidence · ahead of 44% of stocks on this exchange
Trend34
Momentum63
Stability (higher is calmer)27
Liquidity86
Income–

Five-year price chart navy: price · brown: 200-day average

24.8459.0993.341281622021-112023-022024-052025-082026-10

About the company

Viridien, formerly known as CGG, is a geoscience company based in France. It gathers and processes seismic data for oil and gas exploration and production, helping energy companies image underground rock formations. The company also offers reservoir characterization, software and geological consulting services, and it has extended its sensing and monitoring technology into areas such as earth observation and industrial measurement. Its customers are mainly energy firms, national oil companies and other operators of subsurface resources around the world.

Viridien trades under the code VIRI on the Euronext Paris in France, with its price quoted in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Viridien (VIRI) trades on the Euronext Paris in France. It last closed at EUR 95.90 on 27 October 2026.

Its price-based Market X-Ray is 49 out of 100 (a weak price profile), ranking 351 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 27.4% and over the last three months it rose 13.9%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Viridien (VIRI)

The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris

Lens and metricValueScoreReading
Trend34 · WeakBelow its long-term averages and far from its highs.
Above 200-day average-10.0%
From 52-week high-37.9%
Momentum63 · FairTypical recent returns for this exchange.
3-month return13.9%
6-month return-36.7%
12-month return, skipping the last month22.4%
Stability (higher is calmer)27 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)65.2%
Worst drawdown, 1 year (smaller is calmer)-50.4%
Liquidity86 · StrongTrades actively.
Average daily value traded2.77M EUR
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Liquidity: Trades actively.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week+10.1%
1 month+4.0%
3 months+13.9%
6 months−36.7%
1 year+27.4%
3 years+47.8%
5 years+47.0%

Signals

50-day / 200-day average89.41 / 106.54
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)3.97

Technical summary

DailyBullish11 bullish · 1 neutral · 4 bearish
WeeklyStrongly bullish9 bullish · 1 neutral · 2 bearish
MonthlyNeutral4 bullish · 1 neutral · 3 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 28 Oct 2026